Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims resulting from an investigation into its epilepsy medication Depakote, the second-largest drug-marketing settlement ...

Scientists recommended last week that the Food and Drug Administration approve an epilepsy drug to treat manic-depression, making it the first new drug for the devastating mental illness in 25 years.

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability stemming from its off-label promotion of Depakote, a drug that controls seizures. The ...

Over ten years ago, the Food and Drug Administration (FDA) determined that pregnant women who take Depakote (valproate) have a much higher chance of giving birth to a baby who suffers low IQ or a ...

NEW YORK, June 5 (Reuters) - Mylan Inc said on Thursday it settled patent litigation with Abbott Laboratories Inc over Abbott's Depakote ER drug for epilepsy and bipolar disorder that allows the ...

NEW YORK (Reuters Health) - The safety of a popular drug for seizures took another hit Wednesday when researchers pinned a handful of major birth defects on the medication. Earlier research had shown ...